Fibrobiologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.06

-0.09 (-7.83%)

As of Aug 15, 2:31 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,809.4% upside

Low Target $14.74

Average Target $20.24

High Target $23.30

Current Price $1.06

Current
$1.06

Target
$20.24

$14.74 $20.24 avg $23.30

Scenario Analysis

Bear Case

$14.74

1,290.6%

Low target

Base Case

$20.24

+1,809.4%

Avg target

Bull Case

$23.30

+2,098.1%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$12.80

-91.7% from high

52-Week Low

$0.62

+71.0% from low

Target vs 52W High

$20.24

+58.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%